Cargando…

Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting

Alzheimer’s disease (AD) is a devastating neurodegenerative disorder and a leading cause of dementia, with accumulation of amyloid-beta (Aβ) and neurofibrillary tangles (NFTs) as defining pathological features. AD presents a serious global health concern with no cure to date, reflecting the complexi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paudel, Yam Nath, Angelopoulou, Efthalia, Piperi, Christina, Othman, Iekhsan, Aamir, Khurram, Shaikh, Mohd. Farooq
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072620/ https://www.ncbi.nlm.nih.gov/pubmed/32046119 http://dx.doi.org/10.3390/cells9020383

Ejemplares similares

HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
por: Paudel, Yam Nath, et al.
Publicado: (2020)

From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Emerging Pathogenic and Prognostic Significance of Paired Box 3 (PAX3) Protein in Adult Gliomas
por: Angelopoulou, Efthalia, et al.
Publicado: (2019)

Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Embelin prevents amyloid-beta accumulation via modulation of SOD1 in a Streptozotocin-induced AD-like condition: An evidence from in vitro investigation
por: Bhuvanendran, Saatheeyavaane, et al.
Publicado: (2022)

Anti-High Mobility Group Box-1 Monoclonal Antibody Attenuates Seizure-Induced Cognitive Decline by Suppressing Neuroinflammation in an Adult Zebrafish Model
por: Paudel, Yam Nath, et al.
Publicado: (2021)

HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
por: Paudel, Yam Nath, et al.
Publicado: (2018)

Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
por: Mishra, Awanish, et al.
Publicado: (2021)

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Can sars-cov-2 infection exacerbate Alzheimer’s disease? A systematic review
por: Chiara, Villa, et al.
Publicado: (2021)

Pilocarpine Induced Behavioral and Biochemical Alterations in Chronic Seizure-Like Condition in Adult Zebrafish
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Amelioration of Cognitive Deficit by Embelin in a Scopolamine-Induced Alzheimer’s Disease-Like Condition in a Rat Model
por: Bhuvanendran, Saatheeyavaane, et al.
Publicado: (2018)

Recent Developments in Diagnosis of Epilepsy: Scope of MicroRNA and Technological Advancements
por: Bandopadhyay, Ritam, et al.
Publicado: (2021)

New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders
por: Villa, Chiara, et al.
Publicado: (2022)

Embelin Prevents Seizure and Associated Cognitive Impairments in a Pentylenetetrazole-Induced Kindling Zebrafish Model
por: Kundap, Uday Praful, et al.
Publicado: (2019)

Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review
por: Kundap, Uday Praful, et al.
Publicado: (2020)

Orthosiphon stamineus Standardized Extract Reverses Streptozotocin-Induced Alzheimer’s Disease-Like Condition in a Rat Model
por: Retinasamy, Thaarvena, et al.
Publicado: (2020)

The HMGB1-RAGE/TLR-TNF-α signaling pathway may contribute to kidney injury induced by hypoxia
por: Zhang, Cheng, et al.
Publicado: (2019)

Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Ethanolic Extract of Orthosiphon stamineus Improves Memory in Scopolamine-Induced Amnesia Model
por: Retinasamy, Thaarvena, et al.
Publicado: (2019)

Embelin, a Potent Molecule for Alzheimer's Disease: A Proof of Concept From Blood-Brain Barrier Permeability, Acetylcholinesterase Inhibition and Molecular Docking Studies
por: Bhuvanendran, Saatheeyavaane, et al.
Publicado: (2019)

Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
por: Singh, Harbinder, et al.
Publicado: (2022)

The Immune Tolerance Role of the HMGB1-RAGE Axis
por: Watanabe, Haruki, et al.
Publicado: (2021)

Zebrafish as a Model for Epilepsy-Induced Cognitive Dysfunction: A Pharmacological, Biochemical and Behavioral Approach
por: Kundap, Uday P., et al.
Publicado: (2017)

Glycyrrhizin regulates rat TMJOA progression by inhibiting the HMGB1‐RAGE/TLR4‐NF‐κB/AKT pathway
por: Hu, Zhihui, et al.
Publicado: (2021)

The role of HMGB1/RAGE/TLR4 signaling pathways in cigarette smoke‐induced inflammation in chronic obstructive pulmonary disease
por: Lin, Ling, et al.
Publicado: (2022)

Orthosiphon stamineus Proteins Alleviate Hydrogen Peroxide Stress in SH-SY5Y Cells
por: Chung, Yin-Sir, et al.
Publicado: (2021)

sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells
por: Zhang, Fang, et al.
Publicado: (2017)

Plant Derived Phytocompound, Embelin in CNS Disorders: A Systematic Review
por: Kundap, Uday P., et al.
Publicado: (2017)

Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases
por: Pilzweger, Christin, et al.
Publicado: (2015)

Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis
por: Szczepanski, Miroslaw J., et al.
Publicado: (2014)

Mechanism of HMGB1–RAGE in Kawasaki disease with coronary artery injury
por: Qian, Biying, et al.
Publicado: (2020)

RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves' Ophthalmopathy
por: Łacheta, Dominika, et al.
Publicado: (2021)

Increased ACh-Associated Immunoreactivity in Autonomic Centers in PTZ Kindling Model of Epilepsy
por: Akyüz, Enes, et al.
Publicado: (2020)

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
por: Yang, Huan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e5o2uje8srfiujj8aefuumspi4